Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Rachel E Harris, Marina Aloi, Lissy de Ridder, Nicholas M Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Gigi Veereman, Mattias Neyt, Laetitia Bigot, Frank M Ruemmele, Richard K Russell

Journal title: BMJ Open

Journal number: 10/7

Journal publisher: BMJ Publishing Group

Published year: 2020

Published pages: e034892

DOI identifier: 10.1136/bmjopen-2019-034892

ISSN: 2044-6055